NATHEALTH annual event NATEv2018 to be held on Mar 16 Medical Dialogues Bureau10 March 2018 9:30 AM ISTNew Delhi: Healthcare Federation of India (NATHEALTH) is all set to brainstorm on several critical issues concerning the Indian healthcare sector...
Zydus partners Medicure to launch cholesterol drug in US Ruby Khatun Khatun9 March 2018 10:30 AM ISTNew Delhi: Drug firm Zydus Cadila has entered into a definitive agreement with US-based Medicure International Inc to commercialize its new drug...
Sanofi, Evotec team up for research on infectious diseases treatment Ruby Khatun Khatun9 March 2018 10:15 AM ISTPARIS: Sanofi and Evotec said they had started exclusive talks over accelerating research into the treatment of infectious diseases, and added on...
FDA panel backs Pfizer's Xeljanz as bowel disease treatment Ruby Khatun Khatun9 March 2018 10:00 AM ISTPfizer Inc’s Xeljanz should be approved to treat patients with moderate to severe ulcerative colitis, a chronic bowel disease, a U.S. Food and Drug...
Roche names William Pao as research and development head Ruby Khatun Khatun9 March 2018 9:45 AM ISTZURICH: Swiss drugmaker Roche said it will put a cancer specialist at the helm of its Swiss-based research efforts in April after the scientist who...
FDA receives new reports of issues with Bayer’s birth control device Essure Ruby Khatun Khatun9 March 2018 9:30 AM ISTThe U.S. Food and Drug Administration (FDA) is investigating new reports of Bayer’s implanted birth control device Essure causing problems during...
India, Malaysia sign agreement on traditional systems of medicine Medical Dialogues Bureau8 March 2018 10:45 AM ISTNew Delhi: The Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in a written reply to a question in Rajya Sabha has said that...
Sanofi may seek US approval for Dengvaxia despite Philippines outrage Ruby Khatun Khatun8 March 2018 10:30 AM ISTPARIS: French pharmaceuticals group Sanofi says it will decide shortly whether to seek regulatory approval for dengue vaccine Dengvaxia in the United...
EU medicines agency suspends and recall Biogen, AbbVie MS drug Zinbryta Ruby Khatun Khatun8 March 2018 10:15 AM ISTEurope’s medicines regulator recommended the immediate suspension and recall of Biogen Inc and AbbVie Inc’s multiple sclerosis drug Zinbryta,...
Novartis, US partner plan remote trials to boost participation Ruby Khatun Khatun8 March 2018 9:45 AM ISTZURICH: Novartis plans up to 10 clinical trials over three years using a U.S. partner’s mobile technology to help free patients from burdensome...
Merck, Eisai in deal to further develop, sell Eisai cancer drug Ruby Khatun Khatun8 March 2018 9:30 AM ISTNEW YORK: Merck & Co Inc and Japan’s Eisai Co Ltd announced a potential multibillion-dollar collaboration to develop and sell Eisai’s cancer drug...
FDA approves new HIV treatment for patients having limited treatment options Ruby Khatun Khatun7 March 2018 11:00 AM ISTThe U.S. Food and Drug Administration (FDA) approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living...
